Skip to main content
ImmuneCited

Resveratrol 관련 만성 염증

C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

Key Study Findings

Review
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Review
Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future Directions.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

In Vitro
Resveratrol derivative SH-707 inhibits NLRP3 inflammasome activation via a sirtuin 1-dependent pathway.
Dose: None vs: LPS-induced septic mouse model vs control Outcome: IL-1β secretion and NLRP3 inflammasome activation 효과: None None

대상 집단: Macrophages and LPS-induced septic mouse model

Other
Gut microbiota-metabolite crosstalk mediates icariin's protection against obesity-induced spermatogenic dysfunction through NF-κB/AMH axis in Sertoli …
Dose: None vs: HFD mouse model vs control Outcome: Testicular morphology and spermatogenesis markers 효과: None None

대상 집단: HFD-induced obese mouse model (spermatogenesis)

Key Statistics

5

연구

300

참여자

Positive

C

등급

Referenced Papers

Voprosy pitaniia 2023 19 인용
Cancer investigation 2023 6 인용
European journal of … 2020 91 인용
International journal of … 2018 248 인용
Current medicinal chemistry 2018 13 인용
Current pharmacology reports 2015
Current drug targets 2006 92 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
150-500 mg/day
immunesupport:
250-500 mg/day trans-resveratrol

상한량: No established UL; generally well-tolerated up to 1,500 mg/day

연구에서 사용된 용량

용량 기간 효과 N
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

권장 복용 시간: With meals

Safety & Side Effects

보고된 부작용

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Joint pain at very high doses (>2.5 g/day)
  • Kidney issues at extremely high doses (case reports)

알려진 상호작용

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • CYP1A2, CYP3A4 substrates (may inhibit metabolism)
  • Estrogen-sensitive conditions (weak estrogenic activity)

일일 최대 섭취 허용량: No established UL; generally well-tolerated up to 1,500 mg/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Resveratrol help with 만성 염증?
Based on 5 studies with 300 participants, there is limited but promising evidence that Resveratrol may support 만성 염증 management. Our evidence grade is C (Some Evidence).
How much Resveratrol should I take for 만성 염증?
Studies have used various dosages. A commonly studied range is 150-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Joint pain at very high doses (>2.5 g/day), Kidney issues at extremely high doses (case reports). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and 만성 염증?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

References

  1. [1] Zhuyubing Fang et al.. ESC Heart Fail. 2025. Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues. doi:10.1002/ehf2.14947 PubMed
  2. [2] Monika Martiniakova et al.. Nutrients. 2025. Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus. doi:10.3390/nu17020275 PubMed
  3. [3] Hygerta Berisha et al.. Nutrients. 2025. Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk. doi:10.3390/nu17050776 PubMed
  4. [4] Kazuhiko Nakadate et al.. Int J Mol Sci. 2025. Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications. doi:10.3390/ijms26115206 PubMed
  5. [5] Fadiyah Jadid Alanazi et al.. Pathol Res Pract. 2025. Pathological interplay of NF-κB and M1 macrophages in chronic inflammatory lung diseases. doi:10.1016/j.prp.2025.155903 PubMed
  6. [6] Mohamed Ahmed. Immun Ageing. 2025. Targeting aging pathways with natural compounds: a review of curcumin, epigallocatechin gallate, thymoquinone, and resveratrol. doi:10.1186/s12979-025-00522-y PubMed
  7. [7] Jitendra Kumar Sinha et al.. Mol Neurobiol. 2025. The Potential of Mitochondrial Therapeutics in the Treatment of Oxidative Stress and Inflammation in Aging. doi:10.1007/s12035-024-04474-0 PubMed
  8. [8] Mahsa Yavari et al.. Nutrients. 2025. Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids. doi:10.3390/nu17071203 PubMed
  9. [9] Sherif Hamidu et al.. J Aging Res. 2025. Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products. doi:10.1155/jare/8832992 PubMed
  10. [10] Toshiki Otoda et al.. Biomedicines. 2025. Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future Directions. doi:10.3390/biomedicines13051053 PubMed
  11. [11] Angela Falvino et al.. Int J Mol Sci. 2025. Which Approach to Choose to Counteract Musculoskeletal Aging? A Comprehensive Review on the Multiple Effects of Exercise. doi:10.3390/ijms26157573 PubMed
  12. [12] Panagiotis Theodosis-Nobelos et al.. Curr Issues Mol Biol. 2025. Antioxidant Naturally Occurring Pleiotropically Acting Bioactive Compounds, as Polymeric Nanotherapeutics Against Autoimmune Diseases Progression. doi:10.3390/cimb47060411 PubMed
  13. [13] Kyung Tae Kim et al.. Int Immunopharmacol. 2025. Resveratrol derivative SH-707 inhibits NLRP3 inflammasome activation via a sirtuin 1-dependent pathway. doi:10.1016/j.intimp.2025.115049 PubMed
  14. [14] Yuhan Wang et al.. Front Immunol. 2025. Research progress on traditional Chinese medicine compounds in autoimmune-related skin diseases. doi:10.3389/fimmu.2025.1629288 PubMed
  15. [15] Qiumei Huang et al.. Phytomedicine. 2025. Gut microbiota-metabolite crosstalk mediates icariin's protection against obesity-induced spermatogenic dysfunction through NF-κB/AMH axis in Sertoli cells. doi:10.1016/j.phymed.2025.157490 PubMed
  16. [16] Kamila Kasprzak-Drozd et al.. Int J Mol Sci. 2024. Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? doi:10.3390/ijms25073746 PubMed
  17. [17] Myungkyung Noh et al.. J Hazard Mater. 2024. Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease. doi:10.1016/j.jhazmat.2023.132932 PubMed
  18. [18] Ping Zhou et al.. J Ovarian Res. 2024. Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome. doi:10.1186/s13048-024-01354-y PubMed
  19. [19] Daniela Trautmann et al.. Nutrients. 2024. Antitumor Effects of Resveratrol Opposing Mechanisms of Helicobacter pylori in Gastric Cancer. doi:10.3390/nu16132141 PubMed
  20. [20] Huimei Wei et al.. Biol Reprod. 2024. Resveratrol improves follicular development in PCOS rats by inhibiting the inflammatory response and pyroptosis of granulosa cells. doi:10.1093/biolre/ioae160 PubMed
  21. [21] Meir Djaldetti. Oncol Res. 2024. Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers. doi:10.32604/or.2024.049745 PubMed
  22. [22] Xuefei Zhang et al.. Int J Nanomedicine. 2024. Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies. doi:10.2147/IJN.S477820 PubMed
  23. [23] Yang Yang et al.. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. [Protective effect and mechanism of resveratrol on vascular endothelial cells]. doi:10.3760/cma.j.cn121430-20240103-00011 PubMed
  24. [24] T N Bobrysheva et al.. Vopr Pitan. 2023. [Polyphenols as promising bioactive compounds]. doi:10.33029/0042-8833-2023-92-1-92-107 PubMed
  25. [25] Ramya Venkat et al.. Cancer Invest. 2023. The Journey of Resveratrol from Vineyards to Clinics. doi:10.1080/07357907.2022.2115057 PubMed
  26. [26] Wajiha Mahjabeen et al.. Complement Ther Med. 2022. Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: … doi:10.1016/j.ctim.2022.102819 PubMed
  27. [27] Karen S Coutinho-Wolino et al.. Nutr Res. 2022. Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives. doi:10.1016/j.nutres.2022.09.001 PubMed
  28. [28] Pan Wang et al.. Nutrients. 2022. Protective Effects of Dietary Resveratrol against Chronic Low-Grade Inflammation Mediated through the Gut Microbiota in High-Fat Diet Mice. doi:10.3390/nu14101994 PubMed
  29. [29] Ibrahim Jantan et al.. J Nutr Biochem. 2021. Dietary polyphenols suppress chronic inflammation by modulation of multiple inflammation-associated cell signaling pathways. doi:10.1016/j.jnutbio.2021.108634 PubMed
  30. [30] Pamela Senesi et al.. Int J Mol Sci. 2021. Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction. doi:10.3390/ijms22157772 PubMed
  31. [31] Md Habibur Rahman et al.. Front Pharmacol. 2020. Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease. doi:10.3389/fphar.2020.619024 PubMed
  32. [32] Danica Michaličková et al.. Eur J Pharmacol. 2020. Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis. doi:10.1016/j.ejphar.2020.172973 PubMed
  33. [33] Ziwei Yang et al.. Am J Reprod Immunol. 2020. Controlling chronic low-grade inflammation to improve follicle development and survival. doi:10.1111/aji.13265 PubMed
  34. [34] Yuxin Xian et al.. Naunyn Schmiedebergs Arch Pharmacol. 2020. Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice. doi:10.1007/s00210-019-01777-1 PubMed
  35. [35] Oleh Lushchak et al.. Geroscience. 2020. Nanodelivery of phytobioactive compounds for treating aging-associated disorders. doi:10.1007/s11357-019-00116-9 PubMed
  36. [36] Binbin Wang et al.. Sci Rep. 2020. Resveratrol attenuates TLR-4 mediated inflammation and elicits therapeutic potential in models of sepsis. doi:10.1038/s41598-020-74578-9 PubMed
  37. [37] Raúl Francisco Pastor et al.. Nutrients. 2020. Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chronic Inflammation in a Cluster of Older Adults with Metabolic Syndrome. doi:10.3390/nu12103149 PubMed
  38. [38] Hourieh Tousian et al.. Iran J Basic Med Sci. 2020. Looking for immortality: Review of phytotherapy for stem cell senescence. doi:10.22038/IJBMS.2019.40223.9522 PubMed
  39. [39] Ana-Maria Dull et al.. Molecules. 2019. Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways. doi:10.3390/molecules24040667 PubMed
  40. [40] Diego de Sá Coutinho et al.. Int J Mol Sci. 2018. Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights. doi:10.3390/ijms19061812 PubMed
  41. [41] Subash Chandra Gupta et al.. Front Immunol. 2018. Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases. doi:10.3389/fimmu.2018.02160 PubMed
  42. [42] Selenay Furat Rencber et al.. J Ovarian Res. 2018. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. doi:10.1186/s13048-018-0427-7 PubMed
  43. [43] Chitra Rajagopal et al.. Pharmacol Res. 2018. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy. doi:10.1016/j.phrs.2017.12.034 PubMed
  44. [44] Jean-Jacques Michaille et al.. Medicines (Basel). 2018. MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol. doi:10.3390/medicines5030074 PubMed
  45. [45] Ivan Carrera et al.. Curr Med Chem. 2018. Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease. doi:10.2174/0929867325666180410100559 PubMed
  46. [46] Enrico Gugliandolo et al.. Pharmacol Res. 2017. Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury. doi:10.1016/j.phrs.2017.06.014 PubMed
  47. [47] Olagide W Castro et al.. Front Neurol. 2017. Resveratrol for Easing Status Epilepticus Induced Brain Injury, Inflammation, Epileptogenesis, and Cognitive and Memory Dysfunction-Are We There Yet? doi:10.3389/fneur.2017.00603 PubMed
  48. [48] Joseph Schwager et al.. Biomed Res Int. 2015. ω-3 PUFAs and Resveratrol Differently Modulate Acute and Chronic Inflammatory Processes. doi:10.1155/2015/535189 PubMed
  49. [49] Rodica P Bunaciu et al.. Curr Pharmacol Rep. 2015. Resveratrol and Malignancies. doi:10.1007/s40495-015-0030-1 PubMed
  50. [50] Bin Wang et al.. Nutr Res. 2013. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity. doi:10.1016/j.nutres.2013.07.016 PubMed
  51. [51] Elena Talero et al.. Curr Pharm Des. 2012. Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer. doi:10.2174/138161212802083725 PubMed
  52. [52] Ling Zhao et al.. Nutr Rev. 2011. Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals. doi:10.1111/j.1753-4887.2011.00394.x PubMed
  53. [53] Saibal Biswas et al.. Mol Nutr Food Res. 2008. Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin. doi:10.1002/mnfr.200700259 PubMed
  54. [54] Irfan Rahman et al.. Curr Drug Targets. 2006. Antioxidant therapeutic targets in COPD. doi:10.2174/138945006777435254 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.